Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Associations of vascular risk and menopause history with Alzheimer's disease in women

EF 2022-23

Résumé
Alzheimer's disease is the leading cause of dementia. Two-thirds of Canadians suffering from Alzheimer's disease are women. The reasons for women's increased risk for Alzheimer's disease are unknown. Menopause occurs when a decline in a hormone called estrogen causes middle-aged women to stop having menstrual periods. Interestingly, going through menopause (and especially early menopause) leads to an increase in cardiovascular conditions such as high blood pressure and high cholesterol. Cardiovascular conditions are associated with dementia and brain pathology in both sexes, but more so in women. This study will investigate the possibility that women's increased risk for Alzheimer's disease is related to both menopause and increased cardiovascular risk. I will examine whether the combination of early menopause and vascular risk factors leads to accelerated cognitive decline and Alzheimer's brain changes in postmenopausal women. To investigate these questions, I will analyze data from adults aged 40-85 who are participating in Canadian and American observational studies. I expect that younger age at menopause and the presence of vascular conditions will work together to increase the risk of cognitive decline and Alzheimer's disease brain changes in women. This study is important because rates of dementia are rising in Canada's aging population. Understanding why women are more vulnerable to Alzheimer's disease is crucial for developing effective ways to prevent and treat dementia in women. If earlier menopause and vascular conditions together increase the risk of Alzheimer's disease, interventions targeting both estrogen loss (such as estrogen replacement therapy) and improved vascular health could substantially reduce the rates of dementia in women.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
475649
Name
Wood Alexander Madeline
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Associations of vascular risk and menopause history with Alzheimer's disease in women
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Amyloid; Cognitive Decline; Menopause; Neuroimaging; Neuropsychology; Sex Differences; Tau; Vascular Risk Factors; Women'S Health
Abstract
Alzheimer's disease is the leading cause of dementia. Two-thirds of Canadians suffering from Alzheimer's disease are women. The reasons for women's increased risk for Alzheimer's disease are unknown. Menopause occurs when a decline in a hormone called estrogen causes middle-aged women to stop having menstrual periods. Interestingly, going through menopause (and especially early menopause) leads to an increase in cardiovascular conditions such as high blood pressure and high cholesterol. Cardiovascular conditions are associated with dementia and brain pathology in both sexes, but more so in women. This study will investigate the possibility that women's increased risk for Alzheimer's disease is related to both menopause and increased cardiovascular risk. I will examine whether the combination of early menopause and vascular risk factors leads to accelerated cognitive decline and Alzheimer's brain changes in postmenopausal women. To investigate these questions, I will analyze data from adults aged 40-85 who are participating in Canadian and American observational studies. I expect that younger age at menopause and the presence of vascular conditions will work together to increase the risk of cognitive decline and Alzheimer's disease brain changes in women. This study is important because rates of dementia are rising in Canada's aging population. Understanding why women are more vulnerable to Alzheimer's disease is crucial for developing effective ways to prevent and treat dementia in women. If earlier menopause and vascular conditions together increase the risk of Alzheimer's disease, interventions targeting both estrogen loss (such as estrogen replacement therapy) and improved vascular health could substantially reduce the rates of dementia in women.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wood Alexander, Madeline
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~